BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders.

[2] BTG was a constituent of the FTSE 250 Index until it was acquired by Boston Scientific in August 2019.

[4] These two organisations were merged by the Government in 1981 to form a new, non-statutory body called the British Technology Group.

[3] Since acquiring the commercialisation rights to magnetic resonance imaging (MRI) (under a revenue share scheme) in 1983, BTG has come to license a large part of the world market in MRI, including licensees such as General Electric and Philips.

[8] In May 2016 BTG plc acquired the Israeli company Galil Medical for US$110 million.